Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
TCA cycle defects and cancer: when metabolism tunes redox state
GLP-1 drugs research: summary GLP1 drugs may move beyond diabetes and weight loss into multidisease therapies This could significantly increase the number and profile of users, including nonobese and older populations Innovations such as oral GLP1s may further accelerate uptake and accessibility For food and beverage, the shift needs to be watched closely to understand behaviour change, consumption patterns and nutritional needs GLP-1s started life as diabetes medications, then took the world by storm for treating obesity
10.1002/jcp.29391 42 LiS.HeY.ChenK.SunJ.ZhangL.HeY.et al (2021)
Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biological variables, and life habits
US$ 22.12
US$ 27.15
US$ 21.86
US$ 24.02
US$ 29.57
US$ 26.36
